To evaluate the effect of MIF on tumor cell killing by GPC2 CAR-T cells, we quantified CAR-T cell killing capacity against MIF-deficient neuroblastoma cells (SK-N-BE2C-shMIF) in co-cultures. This evidence concerns the gene GPC2 and neuroblastoma.